Showing results (1801-1810 of 1,823) with videos related to
Sort By:
Pageof 183
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2021
Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell LymphomaPreetesh Jain, Shuangtao Zhao, Hun Ju Lee, et al.Rejuvenation Research|September 29, 2015
Interaction Between the FOXO1A-209 Genotype and Tea Drinking Is Significantly Associated with Reduced Mortality at Advanced AgesYi Zeng, Huashuai Chen, Ting Ni, et al.Cancer|November 20, 2023
Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 studyMax J Gordon, Lei Feng, Paolo Strati, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2022
Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell LymphomaJason Westin, R Eric Davis, Lei Feng, et al.Journal of Hematology & Oncology|November 10, 2023
Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort studyNarendranath Epperla, Lei Feng, Nirav N Shah, et al.Forensic Science International. Genetics|January 1, 2022
A collaborative exercise on DNA methylation-based age prediction and body fluid typingJi Eun Lee, Jeong Min Lee, Jana Naue, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2020
Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T ConsortiumLoretta J Nastoupil, Michael D Jain, Lei Feng, et al.Nature|October 5, 2012
A map of rice genome variation reveals the origin of cultivated riceXuehui Huang, Nori Kurata, Xinghua Wei, et al.Aging|December 21, 2020
Effects of choral singing versus health education on cognitive decline and aging: a randomized controlled trialLei Feng, Rafael Romero-Garcia, John Suckling, et al.Cancer Cell|July 12, 2022
Poziotinib for EGFR exon 20-mutant NSCLC: Clinical efficacy, resistance mechanisms, and impact of insertion location on drug sensitivityYasir Y Elamin, Jacqulyne P Robichaux, Brett W Carter, et al.Pageof 183